Department of PharmacyBeijing Children’s Hospital, Capital Medical University,Beijing, Beijing, China (People's Republic)
OC 13.4 - Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
Sunday, June 23, 202410:15 – 10:30 ICT
PB0721 - Case Report: Clinical manifestations and therapeutic options following rhTPO-induced neutralizing antibody production in a child with immune thrombocytopenia
Monday, June 24, 202413:45 – 14:45 ICT
PB0604 - Plasma concentration-adjusted dose of eltrombopag for the individualised treatment of immune thrombocytopenia in children：apilot study from Beijing Children’s Hospital
PB0621 - Population pharmacokinetics model of BAY81-8973 in Chinese children with severe haemophilia A
PB0613 - Real-World Use of Emicizumab in Chinese Children with Hemophilia A: Retrospective Data from a Comprehensive Care Center
